Inhibition of glycoprotein processing blocks assembly of spicules during development of the sea urchin embryo by unknown
Inhibition of Glycoprotein Processing Blocks Assembly of 
Spicules during Development of the Sea Urchin Embryo 
Bruce Kabakoff and William J. Lennarz 
Department of  Biochemistry and Molecular Biology,  the University of  Texas  M. D. Anderson Cancer Center, Houston, Texas  77030 
Abstract.  Previous studies have implicated an 130-kD 
glycoprotein containing complex, N-linked oligosac- 
charide chain(s) in the process of spicule formation in 
sea urchin embryos. To ascertain whether the process- 
ing of high mannose oligosaccharides to complex 
oligosaccharides is necessary for spiculogenesis, intact 
embryos and cultures of spicule-forming primary 
mesenchyme cells were treated with glycoprotein pro- 
cessing inhibitors.  In both the embryonic and cell cul- 
ture systems 1-deoxymannojirimycin (1-MMN) and, to 
a lesser extent,  1-deoxynojirimycin (1-DNJ) inhibited 
spicule formation. These inhibitors did not affect gas- 
trulation in whole embryos or filopodial network for- 
mation in cell cultures. Swainsonine (SWSN) and 
castanospermine (CSTP) had no effect in either sys- 
tem. Further analysis revealed the following: (a) 
1-MMN entered the embryos and blocked glycoprotein 
processing in the 24-h period before spicule formation 
as assessed by a twofold increase in endoglycosi- 
dase H  sensitivity among newly synthesized glycopro- 
teins upon addition of 1-MMN; (b)  1-MMN did not 
affect general protein synthesis until after its effects on 
spicule formation were observed; (c) Immunoblot 
analysis with an antibody directed towards the poly- 
peptide chain of the 130-kD protein (mAb A3) demon- 
strated that 1-MMN did not affect the level of the 
polypeptide that is known to be synthesized just before 
spicule formation; (d)  1-MMN and  1-DNJ almost 
completely abolished (>95%) the appearance of mAb 
1223 reactive complex oligosaccharide moiety associ- 
ated with the 130-kD glycoprotein; CSTP and SWSN 
had much less of an effect on expression of this epi- 
tope. These results indicate that the conversion of high 
mannose oligosaccharides to complex oligosaccharides 
is required for spiculogenesis in sea urchin embryos 
and they suggest that the 130-kD protein is one of 
these essential complex glycoproteins. 
ARLY studies on inhibition  of glycoprotein  synthesis 
and embryonic development of sea urchin revealed 
that tunicamycin blocked the process of gastrulation 
(Schneider et al., 1978; Heifetz and Lennarz, 1979). Subse- 
quently, it was established that the sensitivity of the gastrula- 
tion process to tunicamycin could be related to a marked in- 
crease in the level of N-linked glycoprotein synthesis which 
occurs just before gastrulation  (Lennarz,  1983). This re- 
quirement for glycoprotein synthesis was consistent with the 
finding that gastrulation  could also be blocked by inhibiting 
synthesis of dolichyl phosphate (Carson and Lennarz, 1979, 
1981), the lipid  carrier required for oligosaccharide  chain 
assembly in N:linked glycoprotein synthesis. 
These early studies of  the effect oftunicamycin  on develop- 
ment also  revealed that this  drug blocked spiculogenesis 
when added at the late gastrula stage (Schneider et al., 
1978). More recently this apparent requirement for N-linked 
glycoprotein synthesis during spicule formation has received 
greater attention. Carson et al. (1985) established that addi- 
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tion of a monoclonal antibody (mAb 1223) to a culture of 
primary mesenchyme  cells caused a block in spiculogenesis. 
Immunofluorescence studies  showed that the 1223 antigen 
was primary mesenchyme cell-specific. Immunoblot analy- 
sis revealed that one of the proteins containing the 1223 epi- 
tope was a  130-kD polypeptide  whose level of expression 
correlated with the acquisition of the ability of primary mes- 
enchyme cells to accumulate calcium during spicule forma- 
tion.  These observations,  coupled with subsequent  studies 
establishing  that the 1223 antigen was a glycoprotein,  and 
that the mAb 1223 was directed toward a carbohydrate chain 
on the glycoprotein (Farach et al.,  1987; Farach-Carson et 
al., 1989), led us to study both the distribution of this epi- 
tope in the embryo and the nature of the oligosaccharide 
moiety in more detail. These studies have established that 
the epitope on the glycoprotein recognized by mAb 1223 is 
a complex, N-linked oligosaccharide chain (Farach-Carson 
et al.,  1989) that is  found in the cortical granules of the 
egg, disappears after fertilization and reappears  in associa- 
tion with primary mesenchymal cells before spiculogenesis 
(Farach  et al.,  1987; Decker et al.,  1988). Concurrently, 
Raft and co-workers (Angstrom et al.,  1987) demonstrated 
that two other independently  generated monoclonal antibod- 
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1987) also recognized a  n oligosaccharide  group on the same 
130-kD protein, suggesting that it is a highly immunogenic 
mesenchymal  cell marker. 
Given the complex nature of the carbohydrate chain of the 
1223 antigen  and its apparently  essential  role in a step in 
spiculogenesis,  it seemed likely that  inhibitors  of the pro- 
cessing of oligosaccharide  chains  would block spicule for- 
mation.  In this study, we report the results  of biochemical 
and morphological  studies  with such inhibitors  using both 
intact embryos and primary mesenchyme cells in culture. 
The  results  implicate  complex oligosaccharide  chains  in 
general,  and those associated with the 130-kD glycoprotein 
in particular,  in the process of spiculogenesis in the develop- 
ing sea urchin embryo. 
Materials and Methods 
Materials 
Strongylocentrotus  purpumtus were purchased from Pacific Bio Marine 
Supply (Venice, CA) or Marinus (Long Beach, CA). Artificial seawater 
(ASW), ~ (Instant Ocean) was obtained from Aquarium Systems (Mentor, 
OH). [2-3HlMannose (30 Ci/mmol) was from ICN Radiochemicals (Ir- 
vine,  CA).  L-[4,5-3H]-Leucine (156  Ci/mmol) and Nal25I  (carrier free) 
were from Amersham Corp. (Arlington Heights, IL). Goat anti-mouse IgG 
was obtained from Cappel Laboratories (Maivern, PA) and iodination was 
performed using the chloramine T method (Review 18, Amersham Corp.). 
Horse serum, penicillin-streptomycin, and gentamycin sulfate were pur- 
chased from Gibco Laboratories (Grand Island, NY). Endoglycosidase H 
(eodo  H),  deoxymannojirimycin (1-MMN),  deoxynojirimycin (1-DNJ), 
swainsonine (SWSN), and cnstanospermine (CSTP) were purchased from 
Boehringer Mannheim (Indianapolis, IN). All other chemicals used were 
of reagent grade. 
Methods 
Processing Inhibitor Studies in Whole Embryos. Eggs were collected and 
fertilized as described previously (Heifetz and Lennarz, 1979) and, after 
successive washings with ASW to remove sperm, the embryos were resus- 
pended in ASW to a  1% suspension. 5-ml aliquots of this suspension were 
then cultured at 14°C in 9.5 cm  2, 6-well. Costar (Cambridge, MA) dishes. 
The indicated concentration of inhibitors were then added in a small volume 
of ASW. The addition was carded out within 1 h after fertilization, but be- 
fore the first cleavage.  At the stated times after fertilization, aliquots were 
removed for Western blot analysis as described below. Other aliquots were 
removed and the embryos fixed in 2% glutaraldehyde for subsequent pho- 
tography using Nomarski optics and Kodak Panatomic X (ASA 32)  film. 
Processing Inhibitor Studies in Micromere-derived Primary Mesen- 
chyme Cell Cultures. Micromeres were isolated by the procedure of Oka- 
zaki (1975) as modified  by E Wilt (University of  California at Berkeley; per- 
sonal communication). Calcium-free (CFSW) and calcium-, magnesium-free 
sea water (CMFSW) were prepared as described by McClay (1986).  Eggs 
were fertilized in the presence of 3  mM  3-amino-l,2,4-tdazole (Sigma 
Chemical Co., St. Louis, MO) and passed through a 64-#m Nitex filter to 
remove fertilization membranes. The embryos were then cultured in CFSW/ 
ASW (2:1) until after the first cleavage.  The embryos were allowed to settle 
at that point and were resuspended in CFSW until the 16-cell stage. The 
embryos were harvested and maintained at 4°C through the disaggregation 
step. After two washes with CMFSW, the embryos were incubated for 4 rain 
in CMFSW with 1 mM EDTA. The embryos were pelleted by low speed 
centrifugation, resuspended in a small volume of  CFSW and passed through 
a  10-rrd serological pipette several times to disaggregate the embryos. The 
cells were diluted with CFSW to a 10% suspension and 10-ml aliquots were 
layered over 200-ml linear sucrose gradients ranging from 5 % of 0.75 M 
sucrose in 95 % CFSW to 25 % 0.75 M sucrose in 75 % CFSW with a 100-ml 
1. Abbreviations  used in this paper: ASW, artificial seawater; CFSW, cal- 
cium-free  seawater;  CMFSW,  calcium-  and  magnesium-free seawater; 
CSTP,  castanospermine; 1-DNJ,  deoxynojirimycin;  1-MMN, dcoxyman- 
nojirimycin; SWSN, swainsonine. 
cushion of 25 % sucrose. The cells were allowed to settle for 45-60 rain and 
then the micromeres were harvested from just beneath the lysis layer at the 
top of the gradient. About 40 ml of micromere suspension were removed 
per gradient and 7-ml aiiquots of the suspension plated per well of a 6-well 
dish. CaCl2 was added from a  1-M solution to a final concentration of 10 
mM, and the cells were allowed to attach for 1 h before removal of nonad- 
herent cells. The adherent cells were washed once with ASW followed by 
addition of 5 ml of culture media consisting of 3 % (vol/vol) horse serum, 
1% (vol/vol) penicillin-streptomycin,  0.2 g/liter ticareillin disodium (Sigma 
Chemical  Co.,  St.  Louis,  MO),  and  10  rag/liter erythromycin (Abbot 
Laboratories, Irving, TX) in ASW. The micromeres were allowed to attach 
firmly overnight and the following morning various concentrations of  glyco- 
protein processing inhibitors were added in a small volume of ASW. Photo- 
graphic records were made at various times using phase contrast and Kodak 
Panatomic X (ASA 32) film. 
Western Immunoblots 
Aliquots of  embryo cultures  were removed at  designated times and extracted 
overnight in Tris  buffer  containing 2  %  cholate and a mixture of protease 
inhibitors  as described previously (Carson et  al.,  1985). Protein  concentra- 
tions  of  the extracts  were determined by the method of  Lowry et  ai. (1951) 
using BSA as a standard. The extracts (200 ~g protein/lane) were then sepa- 
rated by  SDS-PAGE (8.75%  acrylamide). The transfer to nitrocellulose 
membranes (Schleicher & Schuell, Inc., Keene, NH) and incubation with 
either mAb 1223,  mAb A3, or nSI-labeled goat anti-mouse IgG were as 
described by Farach et al. (1987) with the exception that the blocking buffer 
contained 3 % nonfat dry milk (Carnation) instead of hemoglobin. 
Protein Synthesis 
Rates of protein synthesis were measured at 24, 48, 72 h after fertilization. 
[3HlLeucine (10 #Ci/mi of culture) was added to control and  1-MMN- 
treated embryos. At 5, 10, 15, and 20 rain after addition of radiulabel, l-nil 
aliqunts were removed, placed on ice, and immediately precipitated with 
10% TCA. After two washes with 10%  TCA, the pellets were solubilized 
overnight in 0.1 N NaOH at 37°C. Subsequently, one aliquot was used for 
protein determination and another aliquot for measuring [3H]leucine incor- 
poration. The rates of incorporation of label into protein were determined 
from the initial velocity of [~H]leucine incorporation into TCA precipitable 
materiai/mg protein plotted against the time of incubation. 
Glycopeptide  Analysis 
Embryo cultures (2 % suspension) of 5 ml in 6-well dishes were prepared 
as described above. [2-3H]Mannose (20 #Ci/ml of culture) was added to 
2--4 wells of 1-MMN-treated and control embryos at either 24 or 48 h after 
fertilization. After incubation for 24 h with radiulabel, cultures of like treat- 
ment were pooled and concentrated by gentle centrifngation. The pellets 
were washed three times with CHC13/MeOH  (2:1) and three times with 
CHC13/MeOH/H20 (10:10:3).  The protein pellet was resuspended in 1 vol 
of 0.1 M Tris, pH 8.0, by sonication. Pronase (Calbiochem-Behring Corp., 
San Diego, CA) was dissolved in the "Iris buffer (10 mg/mi) and incubated 
at 50°C for 30 min. An aliquot of the Pronase mixture (0.1 vul) was added 
to the resuspended sea urchin protein pellet along with a drop of toluene 
and the mixture was incubated for 72 h at 37°C, with fresh additions of 
Pronase at 24 and 48 h. After 72 h, the mixture was boded for 20 rain and 
clarified by centrifugation. The supernatant was chromatographed on Bin- 
gel P-4 column (1)<  40 cm) equilibrated with 0.1 M  ammonium bicar- 
bonate. Aliquots of each fraction were assayed for [3H]mannose and the 
glycopeptide containing fractions (V~, 11-25 nil) were pooled, lyophilized, 
and resnspended in 50 mM Na citrate, pH 5.5, with a drop of toluene. Two 
equal portions, with and without endo H (10 mU), were incubated at 37°C 
for 24 h with a subsequent addition of fresh endo H at 12 h. After the incu- 
bation, the mixtures were boiled for 10 rain and clarified by centfifugation. 
The  aiiquots  were  subsequently rechromatographed on  the Biogel  P-4 
column and the fractions were assayed for [3H]mannose to determine sen- 
sitivity of the glycopeptides to endo H. 
Results 
Inhibitors  of both the initial removal of glucose residues and 
the subsequent trimming  of mannose residues during oligo- 
saccharide  chain processing (Elbein,  1987) were tested for 
The Journal  of Cell Biology,  Volume 1  i 1,  1990  392 Figure  1.  Effect of processing inhibitors on embryogenesis. Eggs were fertilized and embryos cultured as described  in Materials and 
Methods. At 72 h postfertilization, embryos treated with 4 mM I-DNJ (A), 2 mM 1-MMN (B), 2 mM CSTP or 80 #M SWSN (C), and 
untreated controls (D) were fixed in 2% glutaraldehyde, and photographed using Nomarski optics. Bar, 5 #m. 
their effect on spicule formation. The inhibitors used were 
1-DNJ  and  CSTP which block both glucosidase I  and II; 
1-MMN which blocks mannosidase I; and SWSN which in- 
hibits mannosidase II. The site of action of these inhibitors 
is shown in scheme I. The inhibitors were added to embryo 
cultures in concentrations previously shown to be effective 
in mammalian systems (Elbein, 1987). The results shown in 
Fig.  1 clearly establish that two of the inhibitors,  1-MMN 
and 1-DNL affected normal embryonic development between 
gastrula and prism stage by impairing or completely block- 
ing  spicule  formation.  In  contrast,  embryos treated with 
CSTP or SWSN were indistinguishable from untreated con- 
trol embryos. The inhibitory effect was  most dramatic in 
1-MMN-treated cultures, where the embryos maintained a 
rounded appearance more associated with gastrula stage em- 
bryos rather than the triangular shape associated with prism 
stage.  Spicule formation in  1-MMN-treated embryos was 
markedly impaired; in many embryos no spicules could be 
detected whereas in others only partial spicules were evi- 
dent. The spicules in 1-DNJ treated embryos were generally 
longer, but still incomplete. In neither group were embryos 
observed with fulMength spicules meeting at the posterior 
of the embryo. The effect on spicule formation was detect- 
able as early as 48 h after fertilization; i.e., at the mid to late 
gastrula stage when nascent spicules are normally first de- 
tectable in the embryos. 
To insure that the observed effect was due to inhibition of 
processing of the oligosaccharide chains on glycoproteins 
and not to a general toxic effect of the inhibitors, the rate of 
protein synthesis was determined in control and  1-MMN- 
treated embryos.  From the results  shown in Table I,  it is 
clear that there was no significant difference  between the two 
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Synthesis 
Rate of incorporation per time (h) 
of development 
Drug treatment  24 h  48 h  72 h 
None  3.6  5.8  6.0 
1-MMN (2 mM)  3.6  5.4  4.2 
Rate  of  incorporation  into  protein  was  measured in  embryo  cultures  as 
described in Materials and Methods and is expressed as cpm of [3H]leucine 
incorporated/rag protein/rain. 
groups of embryos until after 72 h. Thus, at a stage when 
an impairment of spiculogenesis had already occurred (48 h), 
there was no measurable effect on protein synthesis. These 
findings suggest that the primary effect of 1-MMN is not gen- 
eral toxicity. At 72 h, which corresponds to early pluteus 
stage in control embryos, the rate of protein synthesis in the 
1-MMN-treated embryos declined by ~30% relative to the 
untreated embryos. Presumably, the decline in rate at this 
late stage is a secondary consequence of impaired develop- 
ment caused by inhibition of glycoprotein processing. 
To determine whether these processing inhibitors affected 
glycoprotein processing in vivo, we examined the endo H 
sensitivity of [2-3H]mannose-labeled  glycopeptides prepared 
from 1-MMN or control embryo cultures by Pronase diges- 
tion. If 1-MMN blocked processing to complex oligosaccha- 
ride chains, one would expect a greater proportion of the 
glycopeptide (which elutes near the Ib on a Biogel P-4 col- 
umn) would be sensitive to treatment with endo H, a glycosi- 
dase with specificity towards high mannose glycopeptides. 
Such sensitivity would result in the release of smaller molec- 
ular weight oligosaccharides eluting nearer the  V~ of the 
column. Cultures were incubated with [2-3H]mannose  for a 
24-h period starting at either 24- or 48-h postfertilization. 
As shown in Fig. 2,  in the 24- to 48-h labeling interval a 
much larger fraction of the glycopeptides recovered from the 
1-MMN-treated cultures was sensitive to endo H; 72%  of 
the glycopeptides from the drug-treated culture were endo H 
sensitive, whereas only 30%  were sensitive in the control 
culture. In the 48- to 72-h labeling experiment, the results 
were quite similar, with 64%  of the labeled glycopeptides 
being endo H sensitive for treated embryos and only 28 % for 
control embryos. Thus, it is clear that relatively early in de- 
velopment 1-MMN entered the embryos because it affected 
glycoprotein processing by the early gastrula stage. 
Because the major morphological effect resulting from 
1-MMN  and  1-DNJ treatment appeared  to be  related  to 
spiculogenesis, the effect of these drugs was further exam- 
ined in a cell culture system in which isolated micromeres 
differentiate into spicule-forming primary mesenchyme cells. 
After the isolated micromeres became firmly attached to the 
culture dishes, concentrations of processing inhibitors iden- 
tical to those used in the whole embryo studies were added 
to the culture media. As shown in Fig. 3, no differences in 
appearance of the cultured cells were detectable for the first 
48 h of culture. However,  the results shown in Fig. 4 indi- 
cated that by 96 h of culture when spicules normally become 
fully elongated, there were striking effects that exactly paral- 
leled those observed in whole embryos (Fig. 1). Thus, addi- 
tion of SWSN or CSTP had little effect on spiculogenesis, 
whereas  1-DNJ  and  1-MMN  inhibited this process,  with 
1-MMN being the most effective. This impairment of spicule 
formation was noticeable as early as 72 h after culture, when 
nascent spicules first appear (data not shown). It should be 
noted that despite the presence of 1-MMN or 1-DNJ, the cells 
still produced extensive networks of filopodia (Fig. 5). This 
observation indicates that neither 1-MMN nor 1-DNJ were 
toxic in these cultures, and that extensive processing of gly- 
coproteins is not necessary for production of the filopodial 
networks that form before generation of syncytia. Because of 
the small amounts of material in these primary mesenchyme 
cell cultures, we did not attempt parallel labeling studies 
with respect to [~H]leucine incorporation or endo H semi- 
tivity of glycopeptides. However, given the striking similar- 
ity of the results with those observed in whole embryos and 
the lack of effect of the drugs on either cell attachment or 
filopodial network formation, it is reasonable to assume that 
the inhibitors directly affected glycoprotein processing and 
did not exert some general toxic effect in these cell cultures. 
Previous work by Farach et al. (1987) demonstrated that 
a glycoprotein  containing an N-linked complex carbohydrate 
epitope recognized by mAb 1223 plays an essential role in 
spiculogenesis. Consequently, it was of interest to determine 
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Figure 2.  Effect  of  I-MMN  treatment  on  endo  H  sensitivity of 
mannose-labeled N-linked oligosaccharide chains. Eggs were fer- 
tilized  and  embryos cultured  as  described  in  Materials  and 
Methods. [2-3H]mannose was added (20 #Ci/ml culture) to un- 
treated control cultures (A) and cultures treated with 2 mM I-MMN 
(B). After incubation for 24 h, the proteins were extracted, washed, 
pronase digested, and glycopeptides  isolated as described in Mate- 
rials and Methods. One portion of the glycopeptide  preparation re- 
mained untreated (~----~) while another portion was treated with 
endo H (A----A). The two preparations were subsequently chro- 
matographed on Biogel P-4 (1 × 40 cm) to assess the effect  of endo 
H treatment. 
The Journal of Cell Biology, Volume 111,  1990  394 Figure 3. Effect of processing inhibitors on primary mesenchyme  cell cultures at 48 h. Micromere-derived  mesenchyme  cell cultures were 
prepared and inhibitors added as described in Materials and Methods. Photographic records were made at 48 h of cultures treated with 
4 mM 1-DNJ (a), 2 mM I-MMN (b), 2 mM CSTP or 80/zM SWSN (c), and untreated control cultures (d). Bar, 10 #m. 
genesis correlated with a block in expression of the 1223 epi- 
tope. To do this, Western blot analysis with mAb 1223 was 
performedon protein extracts from the variously treated em- 
bryo cultures. As shown in Fig. 6, two major protein bands 
(130- and 205-kD) bearing the 1223 epitope consistently ap- 
peared in control cultures; the presence of 1-DNJ and 1-MMN 
greatly diminished (>95%)  the amount of this epitope in 
both protein species. In contrast, SWSN and CSTP, two pro- 
cessing inhibitors that had virtually no effect  on spiculogene- 
sis, exhibited much less of an affect on expression of this 
epitope.  The availability of an antibody (mAb  A3) to the 
protein portion of the 130-kD species (Anstrom et al., 1987), 
kindly provided by R. Raft, Indiana University, made it pos- 
sible to determine if the processing inhibitors had an effect 
on the level of expression of that polypeptide chain associ- 
ated with the 1223 antigen. The results of the Western blot 
analysis shown in Fig. 7 revealed that there was no decrease 
in the intensity of the band upon 1-MMN treatment. Thus, 
inhibition of processing had no effect on the synthesis of the 
polypeptide chain of the 130-kD  glycoprotein. 
From the results shown in Fig. 6 it is evident that besides 
a diminishment  of  the intensity of  the immunoreactive bands, 
an apparent decrease in molecular weight; i.e.,  a  higher 
mobility was observed for the 1223 antigen upon 1-MMN, 
1-DNJ, or SWSN treatment. This shift is readily apparent for 
the 205-kD protein upon treatment with the aforementioned 
inhibitors and for the 130-kD protein upon SWSN treatment. 
Overexposure of the autoradiogram in Fig. 6 a shows a simi- 
lar  shift in the  130-kD  protein upon  1-MMN  and  1-DNJ 
treatment (data not shown).  The availability of mAb A3 also 
enabled us to establish whether or not the band of  higher mo- 
bility in the vicinity of the 130-kD  protein represented the 
same polypeptide moiety. The results in Fig.  7  show that 
mAb A3 recognized only the 130-kD  protein from control 
embryos and a  species of slightly lower molecular weight 
from the 1-MMN-treated embryos. Having confirmed that 
the two bands of different mobility represent the same poly- 
peptide species in the 130-kD protein, the autoradiograms 
in Fig. 6 were densitometrically scanned to quantitate the 
relative amounts of the immunoreactive carbohydrate epi- 
tope expressed on the glycoprotein with different inhibitor 
treatments. The results, presented in histogramform in Fig. 
8, are consistent with the observed effects of the processing 
inhibitors on spiculogenesis in whole embryo and primary 
mesenchyme cell cultures and clearly support the conclusion 
that a block in processing of the oligosaccharide chain of the 
1223 antigen blocks spiculogenesis. 
In contrast, very little is known about the 205-kD protein. 
The work of Leaf et al. (1987) suggests that it shares a com- 
mon posttranslational modification (i.e., the same N-linked 
oligosaccharide), but that the polypeptide chain is different 
from that of the 130-kD protein. No antibodies are available 
to the polypeptide portion of  the 205-kD protein, and, there- 
fore, we cannot conclude with certainty that the lower too- 
Kabakoff and Lennarz Glycoprotein  Processing and Skeleton  Formation  395 Figure 4.  Effect  of processing inhibitors on spicule formation. Micromere-derived primary mesenchyme cell cultures were prepared as 
described in Materials and Methods. Photographic records were made at 96 h of cells treated with 4 mM I-DNJ (A), 2 mM 1-MMN (B), 
2 mM CSTP or 80 #M SWSN (C), and untreated control cultures (D). Bar, 20 #m. 
lecular mass species in the inhibitor-treated sample is the 
same protein. Because of  this uncertainty no further analysis 
was done of the 1223 epitope on the 205-kD glycoprotein. 
Discussion 
Earlier studies from this laboratory established that N-linked 
glycoprotein synthesis was required for two major morpho- 
genetic events in the development of the sea urchin embryo, 
gastrulation and subsequent skeleton formation (Schneider 
et al.,  1978).  This relationship between glycoproteins and 
formation of the skeleton was later confirmed and extended 
using an in vitro cell culture system containing the spicule, 
forming primary mesenchyme cells  (Mintz  et  al.,  1981; 
Mintz and Lennarz, 1982).  The serendipitous isolation of a 
mAb 1223, enabled us to further explore this relationship. 
It was found that the mAb 1223 bound to the surface of pri- 
mary mesenchyme cells, blocked Ca  2+ deposition and caused 
a subsequent arrest of spiculogenesis in cell culture (Carson 
et al.,  1985).  On the basis of these observations, and the 
finding that an 130-kD protein bearing the 1223 antigen be- 
gan to appear during the mesenchyme blastula stage and 
peaked during late gastrula stage (Farach et al.,  1987),  we 
proposed  that  this  glycoprotein was  involved in  spiculo- 
genesis. 
As mentioned in the introduction, two additional primary 
mesenchyme  cell-specific  monoclonai  antibodies,  desig- 
nated IG8 (McClay et al., 1985) and B2C2 (Anstrom et al., 
1987) exhibit the same cell type specificity and developmen- 
tal expression observed with the 1223 antigen. Anstrom et 
al.  (1987)  established that all three monoclonal antibodies 
recognized the same protein and Leaf et al. (1987) cloned a 
cDNA encoding for msp130 and reported a partial sequence. 
Very recently the complete deduced sequence and the exis- 
tence of a  phospholipid anchor on mspl30 have been re- 
ported (Parr  et al.,  1990).  By use of various glycosidase 
treatments, it has been shown that the epitope recognized by 
B2C2 (Anstrom et al., 1987) and 1223 (Farach et al., 1987) 
is an N-linked oligosaccharide chain (Farach-Carson, 1989). 
Additionally, Farach-Carson et al. (1989) have demonstrated 
that the 1223 epitope is an acidic, complex oligosaccharide 
chain capable of  binding calcium. Indirect evidence also sug- 
gested that the oligosaecharide epitope contains O-acetylated 
sialic acid residues. 
The Journal of Cell Biology, Volume 111,  1990  396 Figure 5. Effect  of processing inhibitors on filapodial network formation. The untreated cell cultures (A) and 1-MMN-treated  cell cultures 
(B) at 96 h are depicted at higher magnification for observation of filapodial networks. The arrows point to examples of such networks. 
Bar, 5 ttm. 
Given (a) the complex nature of the oligosaccharide chain 
of the  130-kD  glycoprotein and (b)  the evidence that this 
130-kD  glycoprotein is involved in the process of spiculo- 
genesis,  it became of interest to study the developmental 
effects of drugs that inhibit processing and thereby prevent 
complex oligosaccharide chain formation. The studies were 
carried out using two inhibitors of the initial glucosidase ac- 
tivities, 1-DNJ and CSTP, and two inhibitors of the subse- 
quent mannosidase activities, 1-MMN and SWSN. None of 
these drugs had any inhibitory effect on morphogenesis dur- 
ing the first 48 h  in culture; blastulation, primary mesen- 
chyme cell ingression and gastrulation proceeded normally. 
However, skeleton formation at the late gastrula-prism stage 
(48 to 72 h) was markedly impaired by 1-MMN and 1-DNJ, 
with 1-MMN being most effective. The other two drugs had 
no effect on the spicule formation process. In contrast, treat- 
ment with tunicamycin, which inhibits all N-linked glyco- 
protein synthesis, blocks both gastrulation and skeletogene- 
sis. This would suggest that high mannose but not complex 
type N-linked oligosaccharides are required for gastrulation, 
whereas certain complex type oligosaccharide chains are re- 
quired for spiculogenesis. 
There are many possible explanations for the observation 
that some of the processing inhibitors are more effective  than 
others in blocking spiculogenesis. If complex oligosaccha- 
ride formation is crucial for spiculogenesis, then it is not sur- 
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sion of  the 1223 epitope in gastrula stage embryos. 
Cultures were prepared, inhibitors added, proteins 
extracted  at  54  h,  and  immunoblots performed 
with  mAb  1223 as  described  in  Materials  and 
Methods. In experiments 1 (a), embryos were un- 
treated (lane 1) or treated with either 4 mM 1-DNJ 
(lane 2) or 2 mM 1-MMN (lane 3). In experiment 
2 (b), embryos were untreated (lane 1), or treated 
with 1 mM CSTP (lane 2), 2 mM CSTP (lane 3), 
40/~M SWSN (lane 4), or 80 #M SWSN (lane 5). 
All lanes contained 200/~g of protein. 
prising that 1-MMN is the most effective inhibitor. By block- 
ing mannosidase I this drug inhibits all possible processing 
of either branch of the oligosaccharide chain (Fuhrmann et 
al.,  1985). In contrast, use of the other inhibitors is usually 
accompanied by "leakage" (see Scheme I), resulting in some 
level of complex oligosaccharide chain formation (Fuhrman 
et al.,  1985).  This is especially true of SWSN, which has 
been clearly established to induce formation of hybrid oligo- 
saccharides with one high mannose branch and one processed 
complex branch (Tulsiani and Touster, 1983; Elbein, 1987). 
In a large number of studies, SWSN had no effect on glyco- 
protein function, and it has been suggested that partial com- 
plex chain formation may be sufficient for the activity of such 
glycoproteins (Elbein,  1987).  The results obtained in this 
study in which SWSN treatment clearly causes a  distinct 
shift in mobility of the 1223 epitope and yet only decreases 
the intensity of the immunoreactive band by '~50 % strongly 
supports this possibility. The ineffectiveness of CSTP and 
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Figure 7. Effect of 1-MMN on  - 
expression of the polypeptide 
chain of the 130-kD protein in  8  ao 
gastrula  stage embryos.  Em- 
bryos were cultured,  1-MMN  8  20 
added,  proteins  extracted  at  ~. 
52 h,  and immunoblots with  lO 
mAb  A3  were  performed  as 
described  in  Materials  and 
Methods. Embryos were either  o 
untreated  (lane 1) or treated 
with 2 mM 1-MMN (lane 2). 
Each lane contained 200 #g of 
protein. 
SWSN may also simply reflect the poorer inhibitory properties 
of these compounds relative to 1-DNJ and 1-MMN, respec- 
tively, thus allowing enough complex carbohydrate forma- 
tion to allow spicule formation to occur. In fact the potency 
of each of these inhibitors has been shown to vary widely de- 
pending on the particular biological system (Fuhrman et al., 
1985), although in general the concentration of 1-DNJ re- 
quired for 50%  inhibition of glucosidase activity is much 
lower than that for CSTP. It is possible that, by further rais- 
ing the concentrations of SWSN and CSTP, a similar effect 
on spiculogenesis would be observed, but the concentrations 
used for these drugs were already quite high and further ele- 
vation would probably introduce general toxicity effects. 
Because it was possible that the inhibitory effects of 1-MMN 
and  1-DNJ  on spicule formation might be unrelated to an 
impairment in complex oligosaccharide chain synthesis, in 
separate experiments we carried out metabolic labeling of 
the polypeptides with  [3H]leucine and the oligosaccharide 
chains with [3H]mannose. The polypeptide labeling experi- 
ments revealed that there was little effect of the processing 
inhibitors on protein synthesis until after the onset of inhibi- 
tion of spiculogenesis. In contrast, when the glycopeptides 
generated  from  [3H]mannose-labeled  glycoproteins  were 
digested with endo H  and then analyzed by gel filtration, 
it was  found that in the presence of the processing inhib- 
itors the proportion of polymannose chains was markedly in- 
creased relative to that of complex chains. Thus, the drugs 
do impair processing 6f the oligosaccharide chains of glyco- 
proteins in the developing embryo and this inhibition occurs 
before spiculogenesis. 
The observations discussed above with respect to spicule 
formation in the intact embryos were confirmed by similar 
studies in primary mesenchyme cells in culture. None of the 
drugs had any effect on the formation of filapodial networks 
that occurs before assembly of  the syncytia in which the spic- 
ule is formed. However, as was observed in the intact em- 
bryos, both 1-MMN and 1-DNJ blocked spiculogenesis in the 
cultured cells with 1-MMN being most effective. Immuno- 
blot analysis of protein extracts from intact embryos with 
mAb  1223  revealed that  the level of the  immunoreactive 
1223 carbohydrate epitope of the 130- and 205-kD proteins 
markedly decreased in the presence of the processing inhibi- 
tors.  The level of the decrease in the  130-kD protein was 
Effect of Processing Inhibitors  on 
Expression of  1223 Antigen 
Figure 8. Quantitation of the effect of processing inhibitors on the 
level of  1223 epitope  expression.  The autoradiograms  (54  h) 
presented in Fig. 6 (solid bars), as well as those obtained from ex- 
tracts at 72 h (hatched bars) from the same cultures (not shown), 
were densitometrically scanned. The levels of the 1223 epitope as- 
sociated with the 130-kD protein were expressed as a percentage 
relative to control levels for the corresponding time point. The mea- 
surements for CSTP and SWSN correspond in Fig. 6 b to lane 3 
(2 mM) and lane 5 (80 ~M). 
found to be consistent with the observed effects of the inhibi- 
tors on spiculogenesis; i.e., the decrease was much more 
marked with  1-MMN (>98%) and  1-DNJ  (96%), as com- 
pared to CSTP (68%) and SWSN (50%). In contrast, the im- 
munoblot analysis using rnAb A3, which is directed toward 
the polypeptide chain of the 130-kD protein demonstrated 
that the level of the protein backbone was unaffected by drug 
treatment. This result, when combined with the fact that syn- 
thesis of this protein begins roughly 24 h subsequent to the 
addition of inhibitors (Farach et al., 1987; Leaf et al., 1987; 
McClay et al., 1985) further corroborates the findings of the 
labeling experiments in intact embryos that demonstrated the 
specificity of the effect of these drugs on glycoprotein pro- 
cessing.  Additionally,  the analysis  with mAb  A3  revealed 
that the apparent molecular mass of the 130-kD protein was 
reduced upon inhibitor treatment, as would be expected if 
the addition of N-acetylglucosamine, galactose, sialic acid, 
and/or other sugar residues did not occur because of a block 
in  glycosidase-mediated processing  of the  newly  formed 
glucosylated,  high-mannose  oligosaccharide  chains.  The 
fact that the mAb 1223 probe for the complex oligosaccha- 
ride chain (Farach-Carson,  1989) recognizes a fainter band 
of lower molecular mass reveals further information about 
the glycoprotein. If there is only one glycosylation site, the 
inhibition of processing of  that oligosaccharide should cause 
complete disappearance of the band when mAb 1223 is used 
as a probe. Sequencing of the cloned mspl30 gene has re- 
vealed six consensus sequences for possible N-linked gly- 
cosylation (Parr, et al., 1990). Our results suggest the possi- 
bility that more than one of these sites is actually glycosylated 
and that most, but not all of the chains on the glycoprotein 
are blocked from being processed by 1-MMN and  1-DNJ. 
Our conclusion from these studies with oligosaccharide 
processing inhibitors is that processing of certain oligosac- 
charide chains from the high-mannose to the complex type 
is essential for spiculogenesis in  sea urchin embryos. Al- 
though complex oligosaccharide chains have been shown to 
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al.,  1986), to the authors' knowledge, this is the first report 
of the necessity of complex oligosaccharide chain formation 
for proper embryonic development. This is in contrast to the 
majority of the other reports in which the role of oligosac- 
charide chain processing in normal cell differentiation has 
been examined. Studies with differentiating myoblasts (Hol- 
land and Herscovics,  1986;  Spearman et al.,  1987; Simard 
and Connolly,  1987; Trudel et al.,  1988), embryonic  brain 
cells (Bhat,  1988), and embryonic  corneal  cells (Overton, 
1988) have all led to the conclusion that glucosidase inhibi- 
tors blocked differentiation, whereas mannosidase inhibitors 
did not. From this it has been inferred that the removal of 
the terminal glucose residues to form high-mannose oligo- 
saccharides,  but not the further processing to form complex 
oligosaccharides,  is necessary for normal differentiation in 
these systems.  Interestingly,  in the study of abnormal cells 
undergoing differentiation, it has been reported that complex 
oligosaccharide chain formation is necessary  for both mu- 
rine sarcoma L-1 cells to become metastatic (Pulverer et al., 
1988)  and for murine P815 tumors to be recognized  and 
lysed by activated mouse macrophages  (Mercurio,  1986). 
Overall, the results of these studies on the effect of 1-MMN 
and 1-DNJ in intact embryos and isolated primary mesen- 
chyme cells have established  a correlation between a block 
in processing of the oligosaccharide chain of glycoproteins 
and impairment of spicule formation. Although these results 
do not exclude the possibility that a number of'different gly- 
coproteins  are involved in spiculogenesis, they do provide 
strong  additional  support  for the earlier  proposal  that the 
130-kD glycoprotein  in particular plays a role in the Ca  2÷ 
deposition process (Carson et al., 1985). Current studies on 
structural characterization  should enable us to gain insight 
into how the oligosaccharide chain of this glycoprotein might 
participate in this important process. 
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